Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02226874 · ClinicalTrials.gov registry record
Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 30
- Enrollment target
NCT02226874: Completed study, sponsored by National Cancer Institute (NCI).
NCT02226874 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02226874 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Background: \- The National Cancer Institute was funded to study how much radiation U.S. veterans who served in the 1950s were exposed to. Researchers want to estimate how much radiation these veterans received. They will use two methods and compare them. One is to interview the veterans and study their military records. The other is to take blood samples and look for certain types of changes in the blood cells. Being exposed to some kinds of radiation is known to cause changes in blood cells. The amount of changes to these cells tells scientists about how much radiation was received. Objectives: \- To better understand how to measure how much radiation a person has received. Eligibility: * Veterans who were exposed to radiation at a specific site in the Pacific in 1954 or other sites in the 1950s. * Veterans close in age to the first group, who have low levels of exposure to radiation. * Men about 25 years old with no exposure to radiation. Design: * Participants will have 1 visit, in their home. * All participants will have blood drawn. This will take 10 minutes. * The exposed veterans will be interviewed. They will answer questions about the nuclear events they experienced. This will take up to 40 minutes. * For the exposed veterans, researchers will look at their military records, if they can. They will estimate how much radiation the veteran received.
Primary Outcome
Comparing dosimetry data between cases and controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-08-26 |
| Est. Completion | 2016-05-31 |
What the finished NCT02226874 record still lists
NCT02226874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02226874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02226874 about?
NCT02226874 is a clinical study titled "Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation". Background: \- The National Cancer Institute was funded to study how much radiation U.S. veterans who served in the 1950s were exposed to. Researchers want to estimate how much radiation these veterans received. They will use two methods and compare them. One is to interview the veterans and study ...
What is the current status of trial NCT02226874?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-08-26. Estimated completion is 2016-05-31.
Who is sponsoring clinical trial NCT02226874?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI